Aimmune Therapeutics, the company behind the AR101 oral immunotherapy (OIT) treatment for peanut allergy, announced on Dec. 20, 2018 that… Read more »
Tag: clinical trials
Difference Maker: A Teen Who Got Involved in Food Allergy Research
Meet the teenager impacting research as an intern and study participant.
Celiac Disease Treatment Licensed and Headed to Late-Stage Clinical Trials
The drug, based on the compound larazotide acetate, has received FDA “fast track” designation.
OIT’s Effects Endure at Low Doses: Stanford Study
In a long-term follow-up study, oral immunotherapy (OIT) patients who were treated for up to five food allergies were able to maintain a high level of desensitization to their allergens, even those taking very low “doses” of their allergens.
FDA Adds Warning for Cardio Risks to Asthma Drug Xolair
Review found slightly increased risk of suffering from heart attacks, mini-strokes with the injectable drug.